Heterotopic Transcatheter Tricuspid Valve Replacement in a Patient With Carcinoid Heart Disease

Case Reports

. 2022 Nov 16;4(23):101679.

doi: 10.1016/j.jaccas.2022.10.011.

eCollection 2022 Dec 7.


Item in Clipboard

Case Reports

Lukas Stolz et al.

JACC Case Rep.



Neuroendocrine tumors can lead to carcinoid heart disease with subsequent development of severe tricuspid regurgitation due to thickening and restriction of the tricuspid leaflets. We present a patient who underwent successful heterotopic transcatheter tricuspid valve replacement for torrential tricuspid regurgitation due to carcinoid heart disease. (Level of Difficulty: Intermediate.).


CT, computed tomography; MRI, magnetic resonance imaging; NYHA, New York Heart Association; TR, tricuspid regurgitation; TV, tricuspid valve; carcinoid heart disease; right-side heart failure; tricuspid regurgitation; tricuspid valve replacement.

Conflict of interest statement

Dr Hausleiter has received research support and speaker honoraria from Edwards Lifesciences. Dr Näbauer has received speaker fees from Abbott Vascular and Edwards Lifesciences. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.

Source link

Back to top button